Lv1
48 积分 2023-10-31 加入
Ca2+/Calmodulin-dependent protein kinase II (CaMKII)-targeted drug discovery: Challenges and strategies
8个月前
已完结
An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor
9个月前
已完结
Rational design of a high-affinity fluorescent probe for visualizing monitoring the amyloid β clearance effect of anti-Alzheimer's disease drug candidates
11个月前
已完结
皖公网安备34019202002308
